Ethic Inc. acquired a new position in shares of Aemetis, Inc (NASDAQ:AMTX – Free Report) in the 2nd quarter, according to the company in its most recent filing with the SEC. The fund acquired 17,795 shares of the specialty chemicals company’s stock, valued at approximately $42,000.
Several other institutional investors also recently bought and sold shares of AMTX. Vanguard Personalized Indexing Management LLC grew its holdings in Aemetis by 48.7% in the second quarter. Vanguard Personalized Indexing Management LLC now owns 19,611 shares of the specialty chemicals company’s stock worth $49,000 after purchasing an additional 6,420 shares during the last quarter. Clear Harbor Asset Management LLC lifted its holdings in shares of Aemetis by 31.0% during the 2nd quarter. Clear Harbor Asset Management LLC now owns 21,950 shares of the specialty chemicals company’s stock valued at $54,000 after purchasing an additional 5,200 shares during the last quarter. Goldman Sachs Group Inc. boosted its position in shares of Aemetis by 71.9% in the 1st quarter. Goldman Sachs Group Inc. now owns 218,404 shares of the specialty chemicals company’s stock worth $380,000 after purchasing an additional 91,367 shares in the last quarter. State of Wyoming purchased a new position in Aemetis during the 1st quarter worth $90,000. Finally, Wellington Management Group LLP grew its stake in Aemetis by 142.2% during the 1st quarter. Wellington Management Group LLP now owns 62,995 shares of the specialty chemicals company’s stock worth $110,000 after buying an additional 36,983 shares during the last quarter. 27.02% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
A number of equities research analysts have commented on the company. Weiss Ratings reiterated a “sell (e+)” rating on shares of Aemetis in a research note on Wednesday, October 8th. Ascendiant Capital Markets upped their price objective on shares of Aemetis from $20.00 to $21.00 and gave the company a “buy” rating in a report on Monday, October 6th. Three research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $17.33.
Aemetis Trading Down 0.5%
Shares of NASDAQ:AMTX opened at $2.13 on Friday. Aemetis, Inc has a twelve month low of $1.22 and a twelve month high of $4.73. The company has a market cap of $134.70 million, a PE ratio of -1.31 and a beta of 1.68. The company’s 50 day moving average is $2.51 and its 200 day moving average is $2.30.
Aemetis (NASDAQ:AMTX – Get Free Report) last announced its quarterly earnings data on Thursday, August 7th. The specialty chemicals company reported ($0.41) EPS for the quarter, missing the consensus estimate of ($0.35) by ($0.06). The business had revenue of $52.24 million for the quarter, compared to analyst estimates of $78.68 million. Equities research analysts predict that Aemetis, Inc will post -2.07 earnings per share for the current fiscal year.
Insider Transactions at Aemetis
In related news, Director Francis P. Barton sold 26,452 shares of the business’s stock in a transaction on Thursday, August 14th. The shares were sold at an average price of $2.53, for a total transaction of $66,923.56. Following the completion of the transaction, the director directly owned 208,518 shares in the company, valued at $527,550.54. The trade was a 11.26% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 14.70% of the stock is owned by corporate insiders.
About Aemetis
Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.
Featured Articles
- Five stocks we like better than Aemetis
- Stock Dividend Cuts Happen Are You Ready?
- Amazon Earnings: 3 Catalysts That Could Drive Shares to $300
- What is a Stock Market Index and How Do You Use Them?
- Why Chipotle Stock May Bounce After a Brutal Sell-Off
- Ride Out The Recession With These Dividend KingsĀ
- Why VGT May Be a Smarter Bet Than Chasing Individual Tech Stocks
Receive News & Ratings for Aemetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aemetis and related companies with MarketBeat.com's FREE daily email newsletter.
